iBio (IBIO) Capital Leases (2016 - 2024)
iBio (IBIO) reported Capital Leases of $53,000 for fiscal Q4 2024 (quarter ended Jun 30, 2024), down 84.9% from $351,000 a year earlier and down 59.2% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Capital Leases (2016 - 2024) Analysis & Trends
Dating back to fiscal Q3 2016, iBio's Capital Leases record includes 34 quarters.
- Capital Leases has a five-year compound annual growth rate of -70.7% (FY2019 to FY2024).
- By fiscal year, Capital Leases came in at $351,000 in FY2023, $30,000 in FY2022 (-99.9%), $31.76 million in FY2021 (-0.8%) and $32.01 million in FY2020 (+29.7%).
- Five-year quarterly Capital Leases spans a low of $30,000 in fiscal Q4 2022 and a high of $32.24 million in fiscal Q1 2020.
- Year over year, Capital Leases has now declined in each of the last four quarters, with growth averaging 198.4% over the last seven quarters.
- The high point for year-over-year Capital Leases in five years was fiscal Q3 2023 (growth of 929.3%); the low point was fiscal Q4 2022 (a decline of 99.9%).
- Per Business Quant data, the three fiscal quarters before Q4 2024 came in at $130,000 (Q3 2024), $205,000 (Q2 2024) and $53,000 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | iBio | 122.79 Mn | 122.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | 205,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 351,000.00 |
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 490,000.00 |
| Sep 30, 2022 | 576,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 31.66 Mn |
| Jun 30, 2021 | 31.76 Mn |
| Mar 31, 2021 | 31.77 Mn |
| Dec 31, 2020 | 31.85 Mn |
| Sep 30, 2020 | 31.93 Mn |
| Jun 30, 2020 | 32.01 Mn |
| Mar 31, 2020 | 32.08 Mn |
| Dec 31, 2019 | 32.16 Mn |
| Sep 30, 2019 | 32.24 Mn |
API Access
iBio Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();